Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus magnesium sulphate for controlled hypotensive anesthesia in rhinoplasty
PACTR202408620568675Phase 2Completed
- Sponsor
- Primary Sponsor
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine and magnesium sulfate in Not applicable (2 arms), sponsored by Primary Sponsor. Primary endpoints: Heart rate and Mean arterial blood pressure. Started Jul 2022; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
Not applicable
Beyond the preview
Go deeper on PACTR202408620568675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202408620568675.